Back to Blog

Vaginal Microbiome and IVF: What Lactobacillus Dominance May Mean for Implantation

Dr. Senai Aksoy · · 7 min read
Medically reviewed on 18 July 2026 - Dr. Senai Aksoy
vaginalmicrobiomeivfsuccesslactobacillus
Vaginal Microbiome and IVF: What Lactobacillus Dominance May Mean for Implantation

Key Takeaways

A Lactobacillus-dominant vaginal microbiome may support implantation, while dysbiosis can be associated with inflammation, implantation failure, or chronic endometritis. The evidence is promising but still evolving, so this is not a magic fertility shortcut. When symptoms, recurrent BV, or repeated IVF failure are present, targeted testing and treatment make more sense than self-prescribed probiotics.

Key evidence: ESHRE Good Practice Recommendations on Recurrent Implantation Failure CDC STI Treatment Guidelines — Bacterial Vaginosis Reschini et al. 2022 — endometrial microbiome sampling and assessment

On this page

Vaginal Microbiome and IVF

When IVF fails more than once, patients often look first at embryo quality or endometrial thickness. Those factors matter, but they are not the whole picture. Research now suggests that the vaginal microbiome may also influence inflammation, implantation, and the likelihood of chronic endometritis in some patients.

This does not mean the microbiome is a magic answer for every failed cycle. It means that in selected cases, especially when symptoms, recurrent bacterial vaginosis, or repeated implantation failure are present, the vaginal environment may deserve a closer look.

What a “Healthy” Vaginal Microbiome Usually Means

Short Answer:

A Lactobacillus-dominant vaginal microbiome, particularly one rich in Lactobacillus crispatus, is generally considered the more protective and stable pattern, while dominance by anaerobic organisms points toward bacterial vaginosis and an unfavorable reproductive environment.

In many reproductive-age women, the vaginal microbiome is dominated by Lactobacillus species. These bacteria help maintain an acidic vaginal pH and may reduce the growth of organisms associated with dysbiosis.

Among them, Lactobacillus crispatus is often associated with a more stable and protective microbial pattern. By contrast, a microbiome dominated by anaerobic organisms such as Gardnerella, Atopobium, or Prevotella is more often linked to bacterial vaginosis, inflammation, and an unfavorable reproductive environment.

Why It May Matter for IVF

Short Answer:

The embryo goes into the uterus, not the vagina, but vaginal dysbiosis is thought to matter through inflammation, bacterial ascent, and altered immune signaling rather than through direct physical contact with the embryo.

The embryo is transferred into the uterus, not the vagina, so the connection is not always obvious. The concern is not the physical transfer itself; it is the inflammatory environment.

Possible pathways include:

These links are biologically plausible, but they are still being studied. That is why microbiome findings should support clinical judgment, not replace it.

Is There a Separate Uterine (Endometrial) Microbiome?

Short Answer:

The uterus is not simply an extension of the vagina — endometrial samples rarely show the same Lactobacillus dominance, and a low Lactobacillus reading inside the uterus does not, by itself, prove the lining is “unhealthy” or unsuitable for transfer.

Patients sometimes assume that if Lactobacillus dominance is protective in the vagina, the same target should apply inside the uterus. The evidence does not support treating the two as one environment.

In a study that used embryo-transfer catheters to sample endometrial fluid alongside matched vaginal swabs from the same women, Lactobacillus-dominant profiles were found in the endometrium in only 8% of cases, and the dominant bacterial genera overlapped between the vaginal and endometrial samples in only 8% of women (Reschini et al., 2022).

The uterine cavity also contains a much smaller bacterial load overall, and endometrial samples are easily contaminated by vaginal or cervical bacteria during collection, which is part of why researchers now favor double-lumen catheters for sampling.

A low Lactobacillus percentage in an endometrial sample is not, on its own, evidence of a problem.

In one cohort of IVF patients with concurrent endometrial microbiome testing, pregnancy rates were comparable between women with a “dysbiotic” endometrium and those with a “eubiotic” one, and some patients became pregnant with 0% Lactobacillus detected in the endometrium (Hashimoto & Kyono, 2019).

Which bacteria genuinely live in the uterus, what thresholds should count as normal, and whether modifying that environment changes live birth rates are all still open questions. This is part of why the ESHRE working group on recurrent implantation failure currently advises against routine vaginal or endometrial microbiome profiling (ESHRE, 2023).

What the Evidence Shows So Far

Short Answer:

Lactobacillus dominance, especially with L. crispatus, is associated with better implantation and pregnancy outcomes in several studies, but testing methods and thresholds vary and the evidence still falls short of supporting routine screening.

Recent studies suggest that a Lactobacillus-dominant microbiome, especially when L. crispatus is abundant, may be associated with better implantation and clinical pregnancy rates. Dysbiosis, meanwhile, tends to show up more often in patients with recurrent implantation failure or chronic endometritis.

At the same time, the evidence has limits:

So the microbiome is promising, but it should not be sold as a shortcut or a guaranteed fix.

Who May Benefit from Evaluation?

Short Answer:

Microbiome evaluation is more worth considering for patients with recurrent BV, repeated implantation failure, unexplained infertility, or suspected chronic endometritis — not as routine testing for a first, otherwise straightforward IVF attempt.

Microbiome testing is more worth considering when a patient has:

For a first IVF attempt in an otherwise straightforward case, routine microbiome testing is less clearly justified.

How to Support a Lactobacillus-Dominant Vaginal Microbiome

Short Answer:

There is no standardized way to reliably “raise” a Lactobacillus reading the way a supplement corrects a vitamin level. The more evidence-based approach is avoiding what disrupts the vaginal flora, treating diagnosed infection properly, and discussing targeted probiotic use — not self-prescribing one.

Patients do not need to self-prescribe aggressive probiotic or antibiotic regimens to “prepare” for IVF. A safer approach is usually more basic:

  1. avoid vaginal douching, antiseptic solutions, and scented intravaginal products
  2. seek evaluation for odor, irritation, unusual discharge, or recurrent BV — rather than starting a probiotic on your own
  3. stop smoking if applicable
  4. use antibiotics and antifungals only when a diagnosis supports them
  5. discuss probiotic use as a targeted, individualized strategy, not a universal rule
  6. do not apply food products such as yogurt directly to the vagina

The best intervention depends on whether the issue is symptoms, recurrent infection, suspected endometritis, or repeated IVF failure.

Where probiotics fit is still genuinely unsettled. CDC’s own STI treatment guidelines conclude that, despite multiple studies of intravaginal Lactobacillus and other probiotic formulations for bacterial vaginosis, “no studies support these products as an adjunctive or replacement therapy for women with BV” (CDC, 2021).

Oral probiotics appear to act mainly by shifting the gut microbiome rather than directly colonizing the vagina, and in one trial did not improve BV cure rates on their own, though they were associated with better long-term vaginal health after a cure was already achieved with antibiotics (Qi et al., 2023).

Whether oral probiotics can reliably shift a low-Lactobacillus vaginal profile toward a Lactobacillus-dominant one in IVF patients specifically is the subject of an ongoing randomized, placebo-controlled trial that has not yet reported results (van Haren et al., 2025).

Dr Aksoy’s clinical perspective

“Lactobacillus is one of the vagina’s natural protective bacteria. But I ask patients not to think of it like a vitamin level — we don’t yet have a treatment as simple and standardized as ‘your Lactobacillus reading is low, so let’s raise it with a probiotic.’

“If there is active bacterial vaginosis, I do not use a probiotic in place of antibiotics. For recurrent flora disruption, in the right patient, I may discuss specific Lactobacillus products as a supportive option — while being explicit that the evidence is limited. A probiotic can be used, but I cannot promise it will reliably correct the flora or raise the chance of pregnancy. It’s also not enough for a label to simply say ‘Lactobacillus’ — strain, dose, and route of administration differ between products.

“My practical advice stays simpler: avoid vaginal douching, antiseptic solutions, and scented genital products; avoid unnecessary antibiotics and antifungals; and if symptoms are present, get evaluated for bacterial vaginosis, candidiasis, or a sexually transmitted infection first, rather than starting a probiotic on your own. I do not recommend applying foods like yogurt directly to the vagina, under any circumstance.

“For ‘should there be Lactobacillus in the uterus too?’ — I explain it this way: the vagina and the uterus are not the same ecosystem. Lactobacillus dominance in the vagina is generally considered protective. The inside of the uterus is a different environment, with far fewer microorganisms, and endometrial samples are easily contaminated by vaginal or cervical bacteria during collection. We cannot simply transplant what we know about the vagina onto the uterus. A low Lactobacillus percentage on an endometrial sample does not, by itself, prove the uterus is unhealthy or unsuitable for transfer — which bacteria genuinely live there, what thresholds count as normal, and whether modifying that environment actually raises the live birth rate are not settled yet.

“What bothers me is the practice of running an expensive microbiome test, telling a patient ‘you don’t have good bacteria in your uterus, that’s why the embryo didn’t implant,’ and then selling an antibiotic-probiotic package as the definitive fix. That turns a research-level association into a proven cause.

“My summary for patients is this: if there is a real clinical problem with the vaginal flora, we treat it. But reaching a specific Lactobacillus percentage in the uterus is not something I consider a standard IVF target today. I treat a proven condition and the patient in front of me — not a test result.”

Request a Case Review

If you have recurrent bacterial vaginosis, repeated implantation failure, or are wondering whether a vaginal or endometrial microbiome finding is relevant to your case, a structured review of your history and prior test results is a more useful starting point than a standalone microbiome panel. You can request a confidential case review to have your file assessed before deciding on next steps.

FAQ

Should every IVF patient test the vaginal microbiome?

No. Routine testing for every patient is not currently supported by strong enough evidence. It is more relevant in selected clinical situations.

Is Lactobacillus crispatus always “good”?

It is generally considered a favorable sign because it is associated with a more stable, acidic vaginal environment. But a single microbiome result should still be interpreted together with symptoms and fertility history.

Can probiotics improve IVF success?

Possibly in selected cases, but they are not a guaranteed fertility treatment. Probiotics should not replace diagnosis and targeted treatment when infection or inflammation is suspected.

Persistent dysbiosis may contribute to an inflammatory environment and is sometimes associated with chronic endometritis, especially in patients with recurrent implantation failure or unexplained infertility.

Should antibiotics be used before every embryo transfer?

No. Antibiotics should be used when there is evidence of infection or another specific indication. Routine, blind use is not a good strategy.

Sources

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.